Page last updated: 2024-08-25

9-aminocamptothecin and flucytosine

9-aminocamptothecin has been researched along with flucytosine in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Lombardo, F; Obach, RS; Waters, NJ	1
Bernt, KM; Li, ZY; Lieber, A; Ni, S; Roffler, SR; Steinwaerder, DS	1

Other Studies

2 other study(ies) available for 9-aminocamptothecin and flucytosine

Article	Year
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Enzyme-activated Prodrug Therapy Enhances Tumor-specific Replication of Adenovirus Vectors. Cancer research, 2002, Nov-01, Volume: 62, Issue:21 Topics: Adenoviridae; Biotransformation; Camptothecin; Cell Cycle; Combined Modality Therapy; Cytopathogenic Effect, Viral; Cytosine Deaminase; DNA Replication; Flucytosine; Fluorouracil; Genetic Therapy; Glucuronidase; Glucuronides; HeLa Cells; Humans; Nucleoside Deaminases; Pentosyltransferases; Prodrugs; Transgenes; Virus Replication	2002

Article

Year

Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.

Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008

Enzyme-activated Prodrug Therapy Enhances Tumor-specific Replication of Adenovirus Vectors.

Cancer research, 2002, Nov-01, Volume: 62, Issue:21

Topics: Adenoviridae; Biotransformation; Camptothecin; Cell Cycle; Combined Modality Therapy; Cytopathogenic Effect, Viral; Cytosine Deaminase; DNA Replication; Flucytosine; Fluorouracil; Genetic Therapy; Glucuronidase; Glucuronides; HeLa Cells; Humans; Nucleoside Deaminases; Pentosyltransferases; Prodrugs; Transgenes; Virus Replication

2002